Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

Simcere China New York

View original content:https://www.prnewswire.co.uk/news-releases/breakthrough-therapy-designation-for-sanbexin-sublingual-tablets-granted-by-the-united-states-food-and-drug-administration-302239018.html